Inspire Medical Systems (INSP) Cash from Financing Activities (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Cash from Financing Activities data on file, last reported at -$7.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities rose 91.47% year-over-year to -$7.5 million; the trailing twelve-month figure through Mar 2026 stood at -$103.2 million (up 26.79% YoY), and the FY2025 full-year result was -$183.4 million, down 250.14% from the prior year.
• Cash from Financing Activities rose to -$7.5 million in Q1 2026, from -$48.3 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $224.1 million in Q3 2022 to a low of -$87.8 million in Q1 2025.
• A 5-year average of $335470.6 and a median of $3.0 million in 2022 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 5732.03% in 2022 and sank 11527.08% in 2025, its largest moves.
• Tracing INSP's Cash from Financing Activities over 5 years: stood at $7.3 million in 2022, then slumped by 238.77% to -$10.1 million in 2023, then slumped by 593.41% to -$70.1 million in 2024, then surged by 31.12% to -$48.3 million in 2025, then soared by 84.51% to -$7.5 million in 2026.
• Business Quant data shows INSP's Cash from Financing Activities at -$7.5 million in Q1 2026, -$48.3 million in Q4 2025, and -$51.1 million in Q3 2025.